Publication: Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL<sup>pro</sup>inhibitors
Issued Date
2008-10-21
Resource Type
ISSN
10958541
00225193
00225193
Other identifier(s)
2-s2.0-52149096469
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Theoretical Biology. Vol.254, No.4 (2008), 861-867
Suggested Citation
Veena Nukoolkarn, Vannajan Sanghiran Lee, Maturos Malaisree, Ornjira Aruksakulwong, Supot Hannongbua Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL<sup>pro</sup>inhibitors. Journal of Theoretical Biology. Vol.254, No.4 (2008), 861-867. doi:10.1016/j.jtbi.2008.07.030 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/18685
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL<sup>pro</sup>inhibitors
Other Contributor(s)
Abstract
Since the emergence of the severe acute respiratory syndrome (SARS) to date, neither an effective antiviral drug nor a vaccine against SARS is available. However, it was found that a mixture of two HIV-1 proteinase inhibitors, lopinavir and ritonavir, exhibited some signs of effectiveness against the SARS virus. To understand the fine details of the molecular interactions between these proteinase inhibitors and the SARS virus via complexation, molecular dynamics simulations were carried out for the SARS-CoV 3CLprofree enzyme (free SARS) and its complexes with lopinavir (SARS-LPV) and ritonavir (SARS-RTV). The results show that flap closing was clearly observed when the inhibitors bind to the active site of SARS-CoV 3CLpro. The binding affinities of LPV and RTV to SARS-CoV 3CLprodo not show any significant difference. In addition, six hydrogen bonds were detected in the SARS-LPV system, while seven hydrogen bonds were found in SARS-RTV complex. © 2008 Elsevier Ltd. All rights reserved.